Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
pipe-505 (1 trial)
pipe-307 (2 trials)
Deafness (Phase 2)
Hearing Loss (Phase 2)
Hearing Loss, Sensorineural (Phase 2)
Trials (3 total)
Trial APIs (2 total)